Shares of Gilead Sciences Inc. GILD, -0.43% slipped 0.43% to $65.39 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX, -0.33% falling 0.33% to 3,577.03 and Dow Jones Industrial Average DJIA, -0.10% falling 0.10% to 29,210.85. The stock’s fall snapped a two-day winning streak. Gilead Sciences Inc. closed $8.73 short of its 52-week high ($74.12), which the company reached on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, -0.02% fell 0.02% to $162.69, Merck & Co. Inc. MRK, -0.69% fell 0.69% to $90.42, and AbbVie Inc. ABBV, -1.09% fell 1.08% to $139.98. Trading volume (6.4 M) remained 822,307 below its 50-day average volume of 7.2 M.